Sangoma Technologies Corp - SANG STOCK NEWS

Sangoma Technologies (TSX: STC; Nasdaq: SANG), a provider of comprehensive Communications as a Service solutions, has announced its participation in the Planet MicroCap Showcase: VEGAS 2025. The event will take place on Wednesday, April 23, 2025 at 8:00 AM PDT.

CEO Charles Salameh will lead the presentation and conduct a Q&A session. The event will be held at the Paris Hotel & Casino in Las Vegas, offering both in-person and virtual attendance options through a live webcast. Investors can schedule one-on-one meetings with Sangoma representatives during the conference.

The company, which offers businesses flexible options including on-premises, cloud-based, or hybrid communications solutions, will make its presentation available on the conference platform for those unable to attend the live session.

Sangoma Technologies (TSX: STC; Nasdaq: SANG) has exceeded its FY25 debt reduction targets ahead of schedule and announced the launch of a Normal Course Issuer Bid (NCIB). The company has issued an irrevocable notice for an additional $2.9 million debt repayment, bringing Q3 total repayments to $7.3 million.

The full repayment of Term Loan 1 has reduced total debt to approximately $53 million at Q3 end, surpassing the original FY25 target of $55-$60 million. The NCIB program will allow Sangoma to purchase up to 1,679,720 shares (5% of outstanding shares) for cancellation between March 27, 2025, and March 26, 2026.

Daily purchases will be to 9,429 shares, with block purchase exceptions available weekly. The company will fund the share buyback through surplus operational cash flow.

Sangoma Technologies (TSX: STC; Nasdaq: SANG) released its Q2 FY2025 results, showing mixed performance. Net cash from operations increased 29.7% year-over-year, exceeding 100% of Adjusted EBITDA for the fourth consecutive quarter. Total revenue was $59.1 million, down 1.7% from Q1 FY2025, primarily due to decreased low-margin third-party product resales.

Key metrics include gross profit of $40.5 million (68.5% margin), Adjusted EBITDA of $10.1 million (17.1% of revenue), and improved churn below 1.0%. Operating expenses decreased 7.3% year-over-year to $41.3 million. Net loss narrowed to $1.9 million from $3.2 million in Q2 FY2024.

The company revised its FY2025 guidance, lowering revenue expectations to $235-240 million from $250-260 million, while maintaining an Adjusted EBITDA target of at least 17% of revenue ($40-42 million).

Sangoma Technologies (TSX: STC; Nasdaq: SANG) has unveiled its proprietary AI platform, Sangoma GenAI, introducing several AI-powered innovations in business communications. The platform includes an Enhanced Conversational IVR for streamlining customer interactions, a Patient Relationship Management System developed with Sphinx Medical's CallMyDoc® for healthcare automation, and Sangoma Scribe for voice record transcription and analysis.

The company has also enhanced its Sangoma CX® contact center solution with GoogleFlow-powered chatbots and AI Assist features to improve agent productivity. These innovations aim to optimize operations, customer engagement, and team collaboration while providing affordable enterprise-grade solutions. Sangoma continues its investment in open source projects Asterisk and FreePBX, with plans to showcase AI integration at the upcoming 20th annual AstriCon conference in Fort Lauderdale.

Sangoma Technologies (TSX: STC; Nasdaq: SANG), a provider of cloud-based Communications as a Service solutions, has announced it will release its second quarter fiscal year 2025 financial results after market close on February 5, 2025. The company will host a conference call the same day at 5:30 PM Eastern Time to discuss the results. Investors can join the call using the dial-in number 1-844-763-8274 (International: +1-647-484-8814) and are requested to dial in 5 minutes before the scheduled start time.

Sangoma Technologies (TSX: STC; Nasdaq: SANG) has partnered with Sphinx Medical Technologies to launch a new Patient Relationship Management (PRM) system, integrating Sangoma's unified communications platform with Sphinx's CallMyDoc® AI-powered IVR system. The solution offers 99.999% uptime and seamlessly integrates with Electronic Health Records (EHR) systems while maintaining HIPAA compliance.

The system leverages CallMyDoc®'s 20 million patient call history and provides features including 24/7 virtual consultations, multilingual support, automated follow-up care, and real-time patient record access. It significantly improves efficiency by reducing call time by 10x and automating tasks like prescription refills and appointment scheduling. The solution includes automated appointment reminders, integrated online booking, and advanced call routing capabilities.

Sangoma Technologies (TSX: STC; Nasdaq: SANG) has partnered with Sphinx Medical Technologies to launch a new Patient Relationship Management (PRM) system, integrating Sangoma's unified communications platform with Sphinx's CallMyDoc® AI-powered IVR system. The solution offers 99.999% uptime and seamlessly integrates with Electronic Health Records (EHR) systems while maintaining HIPAA compliance.

The system leverages CallMyDoc®'s 20 million patient call history and provides features including 24/7 virtual consultations, multilingual support, and automated follow-up care. Key benefits include streamlined communication with real-time patient record access, automated prescription refills, appointment scheduling, and nearly 100% accurate AI transcription. The solution reduces call time by 10x and includes automated appointment reminders, integrated online booking, and advanced call routing.

Universal Display (Nasdaq: OLED) announced the appointment of April E. Walker to its Board of Directors, effective January 1, 2025, expanding the board to 11 members. Walker brings over 30 years of leadership experience from companies including Microsoft, MetLife, NBCUniversal, and Salesforce, with expertise in artificial intelligence, cybersecurity, and digital innovation.

Walker currently serves as a strategic advisor and holds positions at Drexel University Solutions Institute. She has an MBA from MIT Sloan School of Management, specialized certifications in AI and Machine Learning, and an MS in Engineering Management from George Washington University. She also serves on the Board of Sangoma Technologies

Sangoma Technologies (TSX: STC; Nasdaq: SANG) has announced its participation in The Benchmark Company's 13th Annual Discovery One-on-One Investor Conference. The event will take place on December 11th, 2024 at the New York Athletic Club in New York City.

The conference provides a unique platform for emerging growth and dynamic publicly traded companies to connect with institutional and individual investors in a one-on-one format. Charles Salameh, Chief Executive Officer of Sangoma, will be conducting one-on-one meetings with investors and analysts throughout the conference day.

Interested investors and analysts can request meetings with Mr. Salameh through the conference's online registration system.